UC HEALTH LINE: Arm Therapy 'Rewires' Brain After Stroke
A study led by Stephen Page, PhD, and published in the August 2006 issue of Archives of Physical Medicine and Rehabilitation, reports that when stroke patients participate in modified constraint-induced movement therapy, or mCIMT, areas of their brain normally used for other functions are recruited to help move the affected arm.
Patients in the study were offered 10 weeks of mCIMT, in which restraint of the unaffected arm forced them to use their affected arm for everyday tasks.
Study participants were given 30-minute therapy sessions three times a week. They were asked to follow up at home, still using only their affected arm for five hours each day, five days a week.
Previous studies have shown that mCIMT can improve arm function in patients, but we werent quite sure how it was working, says Page, assistant professor and director of research in the department of physical medicine and rehabilitation. The cool thing about this study is that we now know the mechanism.
That mechanism, referred to by the researchers as cortical reorganization, was confirmed through functional magnetic resonance imaging (fMRI) scans of the participants at the beginning and end of the study.
In patients who benefited from constraint therapy, says Page, fMRI scans clearly show activity in brain areas that werent active at the start of the study
To our knowledge, says Page, this is the first study showing this kind of rewiring. We think its particularly important to stroke patients, because this particular outpatient therapy is often covered by insurance providers, so its quite accessible.
Coauthorsall from UCinclude Brett Kissela, MD, Jing-Huei Lee, PhD, Peter Levine, Stephen Strakowski, MD, and
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.